Results 231 to 240 of about 214,380 (250)

Lymphodepletion strategies to potentiate adoptive T-cell immunotherapy – what are we doing; where are we going?

Expert Opinion on Biological Therapy, 2021
John Maher, Natasha Bechman
exaly  

In Vivo Tracking of Cell Viability for Adoptive Natural Killer Cell-Based Immunotherapy by Ratiometric NIR-II Fluorescence Imaging

Angewandte Chemie - International Edition, 2021
Huang-Hao Yang, Ming Wu, Lichao Su
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy

OncoImmunology, 2021
Jun Ren, Shuo Wang, Herbert Kim Lyerly
exaly  

Adoptive Immunotherapy for Cancer or Viruses

Annual Review of Immunology, 2014
Bruce L. Levine, Joseph A. Fraietta, Marcela V. Maus   +2 more
exaly  

The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy

Molecular Therapy, 2019
Katalin Karikó, Jessica B Foster, David M Barrett   +2 more
exaly  

Adoptive Immunotherapy for EBV-associated Malignancies

Leukemia and Lymphoma, 2005
Helen Heslop, Cliona M Rooney, Stephen Gottschalk   +2 more
exaly  

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

Lancet, The, 2000
Susumu Yamasaki, Teruaki Sekine, S Hirohashi   +2 more
exaly  

Adoptive immunotherapy for cancer

Immunological Reviews, 2014
Marco Ruella
exaly